1. Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine

   News item 27 March 2021 Pages: 1 - 1

2. Benefits of COVID-19 Vaccine AstraZeneca outweigh risks of blood clots

   News item 27 March 2021 Pages: 2 - 2

3. March 2021 PRAC meeting highlights include COVID-19 vaccine update

   News item 27 March 2021 Pages: 3 - 3

4. AEs impact cost effectiveness of smoking cessation therapies

   Clinical study 27 March 2021 Pages: 4 - 4

5. Drug-induced liver injury: overview of causality assessment

   Clinical study 27 March 2021 Pages: 5 - 5

6. Dupilumab-associated adverse events

   Clinical study 27 March 2021 Pages: 6 - 6

7. Measles vaccination campaign: adverse events following immunisation

   Clinical study 27 March 2021 Pages: 7 - 7

8. Metabolic changes with tenofovir alafenamide vs TDF

   Clinical study 27 March 2021 Pages: 8 - 8

9. Universal COVID-19 vaccination cost saving unless anaphylaxis rate high

   Clinical study 27 March 2021 Pages: 9 - 9

10. Other adverse reaction research

    News item 27 March 2021 Pages: 10 - 10

11. Psoralea corylifolia

    Case report 27 March 2021 Pages: 11 - 11

12. Abatacept

    Case report 27 March 2021 Pages: 12 - 12

13. Acenocoumarol

    Case report 27 March 2021 Pages: 13 - 13

14. Acetazolamide

    Case report 27 March 2021 Pages: 14 - 14

15. Acetic acid/tacrolimus

    Case report 27 March 2021 Pages: 15 - 15

16. Acetylcysteine

    Case report 27 March 2021 Pages: 16 - 16

17. Aciclovir/amoxicillin

    Case report 27 March 2021 Pages: 17 - 17

18. Aciclovir/immunosuppresants

    Case report 27 March 2021 Pages: 18 - 18

19. Acitretin/ciclosporin/methotrexate

    Case report 27 March 2021 Pages: 19 - 19

20. Adalimumab

    Case report 27 March 2021 Pages: 20 - 20

21. Adalimumab

    Case report 27 March 2021 Pages: 21 - 21

22. Adalimumab

    Case report 27 March 2021 Pages: 22 - 22

23. Adalimumab

    Case report 27 March 2021 Pages: 23 - 23

24. Adalimumab

    Case report 27 March 2021 Pages: 24 - 24

25. Adalimumab/azathioprine

    Case report 27 March 2021 Pages: 25 - 25

26. Adalimumab/corticosteroids/immunosuppressants

    Case report 27 March 2021 Pages: 26 - 26

27. Adapalene

    Case report 27 March 2021 Pages: 27 - 27

28. Albendazole

    Case report 27 March 2021 Pages: 28 - 28

29. Alemtuzumab

    Case report 27 March 2021 Pages: 29 - 29

30. Alendronic-acid/denosumab

    Case report 27 March 2021 Pages: 30 - 30

31. Allopurinol/phenobarbital

    Case report 27 March 2021 Pages: 31 - 31

32. Alprazolam abuse

    Case report 27 March 2021 Pages: 32 - 32

33. Alprazolam/bromazepam/clonazepam

    Case report 27 March 2021 Pages: 33 - 33

34. Alteplase/bivalirudin

    Case report 27 March 2021 Pages: 34 - 34

35. Alteplase/icatibant

    Case report 27 March 2021 Pages: 35 - 35

36. Amantadine/levodopa/carbidopa

    Case report 27 March 2021 Pages: 36 - 36

37. Amfetamine/dexamfetamine

    Case report 27 March 2021 Pages: 37 - 37

38. Amikacin

    Case report 27 March 2021 Pages: 38 - 38

39. Amikacin/ethambutol

    Case report 27 March 2021 Pages: 39 - 39

40. Amiodarone

    Case report 27 March 2021 Pages: 40 - 40

41. Amiodarone/metoprolol

    Case report 27 March 2021 Pages: 41 - 41

42. Amodiaquine/pyrimethamine/sulfadoxine

    Case report 27 March 2021 Pages: 42 - 42

43. Amoxicillin/clavulanic acid

    Case report 27 March 2021 Pages: 43 - 43

44. Amoxicillin/clavulanic acid/minocycline

    Case report 27 March 2021 Pages: 44 - 44

45. Amoxicillin/clavulanic-acid

    Case report 27 March 2021 Pages: 45 - 45

46. Amphotericin-B-liposomal/dexamethasone

    Case report 27 March 2021 Pages: 46 - 46

47. Anastrozole/clomifene/levofloxacin interaction

    Case report 27 March 2021 Pages: 47 - 47

48. Antibacterials

    Case report 27 March 2021 Pages: 48 - 48

49. Antiepileptic drugs

    Case report 27 March 2021 Pages: 49 - 49

50. Antiepileptics/propofol

    Case report 27 March 2021 Pages: 50 - 50